Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Peter R. Bremner"'
Autor:
Peter R. Bremner, Ruby Birk, Noushin Brealey, Afisi S. Ismaila, Chang-Qing Zhu, David A. Lipson
Publikováno v:
Respiratory Research, Vol 19, Iss 1, Pp 1-10 (2018)
Abstract Background Single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) 100/62.5/25 μg has been shown to improve lung function and health status, and reduce exacerbations, versus budesonide/formoterol in patients with chronic obs
Externí odkaz:
https://doaj.org/article/ccd29838d82b4091a09d185b46fc79d5
Autor:
Ruby Birk, Chang-Qing Zhu, David A. Lipson, Peter R. Bremner, Noushin Brealey, Afisi S. Ismaila
Publikováno v:
Respiratory Research
Respiratory Research, Vol 19, Iss 1, Pp 1-10 (2018)
Respiratory Research, Vol 19, Iss 1, Pp 1-10 (2018)
Background Single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) 100/62.5/25 μg has been shown to improve lung function and health status, and reduce exacerbations, versus budesonide/formoterol in patients with chronic obstructive
Autor:
Graham Luscombe, Peter R. Bremner, Neil Johnson, Barbara A. Prillaman, Anahi Yanez, Alex Dimitroff, Chae-Seo Rhee
Publikováno v:
Allergy & Rhinology
Allergy & Rhinology, Vol 7 (2016)
Allergy & Rhinology, Vol 7 (2016)
Background Corticosteroid nasal sprays are the mainstay of treatment for allergic rhinitis. These sprays have sensory attributes such as scent and/or odor, taste and aftertaste, and run down the throat and/or the nose, which, when unpleasant, can aff
Autor:
A. William Musk, Michael Musk, Gerard Ryan, Alan L. James, Randolph Spargo, Nicholas de Klerk, Sally Young, Peter N. Le Souëf, Catherine Murray, Peter R. Bremner
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 158:1724-1729
To estimate the prevalence of respiratory symptoms, bronchial hyperresponsiveness, smoking, and atopy in a population of Australians of Aboriginal descent (AAD), to determine the association of these and other factors with lung function, and to compa
Autor:
Kate McCarney, Michael Millward, Peter A Kendall, Grant W. Waterer, Arthur W. Musk, Elizabeth Geelhoed, Sharifa Dina, Peter R. Bremner, Y. C. Gary Lee, Edward T.H. Fysh, Sue Morey
Publikováno v:
Chest. 142(2)
Patients with malignant pleural effusion (MPE) have limited prognoses. They require long-lasting symptom relief with minimal hospitalization. Indwelling pleural catheters (IPCs) and talc pleurodesis are approved treatments for MPE. Establishing the i